The conversation focused on recent developments surrounding a newly granted device patent, often referred to as the "IBAL patent." A key theme that emerged was how this patent, covering ionic cofactor matrices and essential ion delivery for local applications, is shaping the strategy of a nonprofit organization dedicated to advancing this technology across various medical and commercial fields. The discussion explored the innovative spin-out model being used to create specialized development companies for different indications such as wound healing, psoriasis, eczema, and skin cancer, each benefiting from shared intellectual property while maintaining independence.

Several points were raised, including the reasoning behind a nonprofit holding patents, the benefits and challenges of the collaborative licensing approach, and the significant impact of recent reimbursement changes in wound care markets. Listeners will also hear about opportunities for researchers, practitioners, patients, and capital partners to participate in the mission, as well as new fundraising mechanisms designed to support the ongoing expansion and accessibility of the technology.

Timestamps:

00:00 Protecting and promoting the technology

04:56 Patent Strategy for Medical Applications

08:08 Collaborative model for IP sharing

13:08 Finding the right people for niche markets

16:31 Collaborating on IP development

18:27 Early manufacturing possibilities

21:10 Ion gel benefits and cost savings

25:23 Pricing Strategy and Profitability

29:38 Support for practitioners and researchers

33:00 Promoting the podcast and fundraiser

37:19 Nonprofit collaboration for fee savings

39:15 Discussing funding challenges

“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/